Use of the eie-recombinant-chagas-biomanguinhos kit to monitor cure of human chagas' disease

We used the EIE‐Recombinant‐Chagas‐Biomanguinhos kit (EIE‐Rec kit) developed by the Oswaldo Cruz Foundation, Brazil, to monitor cure of chagasic patients who were treated during the acute phase of T. cruzi infection. Treated patients were previously studied by parasitological and serological tests a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical laboratory analysis 2002, Vol.16 (3), p.132-136
Hauptverfasser: Silva, Edimilson D., Pereira, Valéria R.A., Gomes, Juliana A.S., Lorena, Virgínia Maria B., Cançado, Joaquim R., Ferreira, Antonio G.P., Krieger, Marco Aurélio, Goldenberg, Samuel, Correa-Oliveira, Rodrigo, Gomes, Yara M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We used the EIE‐Recombinant‐Chagas‐Biomanguinhos kit (EIE‐Rec kit) developed by the Oswaldo Cruz Foundation, Brazil, to monitor cure of chagasic patients who were treated during the acute phase of T. cruzi infection. Treated patients were previously studied by parasitological and serological tests and classified as cured patients (CP) (n = 10), dissociated patients (DP) (n = 6), and noncured patients (NCP) (n = 6). When sera of these patients were assayed by EIE‐Rec kit all sera from NCP and all sera from CP showed positive and negative reactions, respectively. These results were in full agreement with those obtained previously by the classical tests. Two DP showed a positive reaction; the remaining four displayed a negative reaction, similar to that observed in sera from nonchagasic (NCh) individuals, and could therefore be considered CP. Our results suggest that the EIE‐Rec kit could be used to monitor the efficacy of Chagas’ disease treatment. J. Clin. Lab. Anal. 16:132–136, 2002. © 2002 Wiley‐Liss, Inc.
ISSN:0887-8013
1098-2825
DOI:10.1002/jcla.10028